InsidersTradesSigma
한독 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 한독 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 한독 has logged 3 reports. Market capitalisation: €116.4bn. The latest transaction was disclosed on 13 March 2026 (Purchase). Among the most active insiders: 이동국. The full history is accessible without an account.
1
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,019 of 27,969 companies
25.9
score / 100
Value27
Quality25
FCF yld-10%
Earn yld-1.8%
EV/EBITDA13.9x
ROE-1.1%
Gross mgn30%
Net mgn-0.4%
Debt/EBITDA10.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 13 March 2026
About 한독
HanDoc is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of drugs and pharmaceutical products.